BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38090112)

  • 21. MicroRNA-145 Inhibits the Activation of the mTOR Signaling Pathway to Suppress the Proliferation and Invasion of Invasive Pituitary Adenoma Cells by Targeting AKT3 in vivo and in vitro [Retraction].
    Onco Targets Ther; 2020; 13():6851. PubMed ID: 32764974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kanglaite Reverses Multidrug Resistance of HCC by Inducing Apoptosis and Cell Cycle Arrest via PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2024; 17():99-100. PubMed ID: 38371878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-937 Inhibits the Malignant Phenotypes of Breast Cancer by Directly Targeting and Downregulating Forkhead Box Q1 [Retraction].
    Onco Targets Ther; 2021; 14():4991-4992. PubMed ID: 34675539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction].
    Onco Targets Ther; 2021; 14():4897-4898. PubMed ID: 34594110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition [Retraction].
    Onco Targets Ther; 2023; 16():751-752. PubMed ID: 37731628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-145-3p inhibits non-small cell lung cancer cell migration and invasion by targeting PDK1 via the mTOR signaling pathway.
    Chen GM; Zheng AJ; Cai J; Han P; Ji HB; Wang LL
    J Cell Biochem; 2018 Jan; 119(1):885-895. PubMed ID: 28661070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction].
    Onco Targets Ther; 2023; 16():1025-1026. PubMed ID: 38090111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor Effect of Triptolide in T-Cell Lymphoblastic Lymphoma by Inhibiting Cell Viability, Invasion, and Epithelial-Mesenchymal Transition via Regulating the PI3K/AKT/mTOR Pathway [Retraction].
    Onco Targets Ther; 2024; 17():303-304. PubMed ID: 38595926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway [Retraction].
    Onco Targets Ther; 2022; 15():85-86. PubMed ID: 35087278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction].
    Onco Targets Ther; 2021; 14():4847-4848. PubMed ID: 34584423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. microRNA-532 suppresses the PI3K/Akt signaling pathway to inhibit colorectal cancer progression by directly targeting IGF-1R [Retraction].
    Am J Cancer Res; 2021; 11(9):4641. PubMed ID: 34659912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction].
    Onco Targets Ther; 2021; 14():4935-4936. PubMed ID: 34611412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retraction: Down-regulation of Rab10 inhibits hypoxia-induced invasion and EMT in thyroid cancer cells by targeting HIF-1α through the PI3K/Akt pathway.
    Fisher L
    RSC Adv; 2021 Jan; 11(8):4442. PubMed ID: 35426997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting insulin-like growth factor-binding protein-3 by microRNA-125b promotes tumor invasion and poor outcomes in non-small-cell lung cancer.
    Wang HH; Wang YC; Wu DW; Hung CS; Chen CY; Lee H
    Tumour Biol; 2017 Apr; 39(4):1010428317694316. PubMed ID: 28378642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-618 Directly Targets Metadherin mRNA to Suppress the Malignant Phenotype of Osteosarcoma Cells by Reducing PTEN-AKT Pathway Output [Retraction].
    Onco Targets Ther; 2021; 14():4963-4964. PubMed ID: 34629879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long Noncoding RNA Sox2 Overlapping Transcript (SOX2OT) Promotes Non-Small-Cell Lung Cancer Migration and Invasion via Sponging microRNA 132 (miR-132) [Retraction].
    Onco Targets Ther; 2021; 14():5003-5004. PubMed ID: 34675544
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Onco Targets Ther; 2023; 16():817-818. PubMed ID: 37849468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway [Retraction].
    Onco Targets Ther; 2023; 16():747-748. PubMed ID: 37719640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-21 Contributes to Cutaneous Squamous Cell Carcinoma Progression via Mediating TIMP3/PI3K/AKT Signaling Axis [Retraction].
    Int J Gen Med; 2023; 16():5159-5160. PubMed ID: 37954653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-559 Plays an Inhibitory Role in the Malignant Progression of Glioblastoma Cells by Directly Targeting Metadherin [Retraction].
    Onco Targets Ther; 2021; 14():4899-4900. PubMed ID: 34594111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.